Clinical trial
Prospective Randomized Controlled Study of Ropivacaine-Poloxamer 407 Based Gel Application and TAP Block for Postoperative Pain Management Following Laparoscopic/Robotic Gastrectomy
NCT06839716 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Controlled Study of Ropivacaine-Poloxamer 407 Based Gel Application and TAP Block for Postoperative Pain Management Following Laparoscopic/Robotic Gastrectomy
- Lead sponsor
- Gangnam Severance Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 1, 2025
- Completion date
- March 31, 2026
- Enrollment
- 134 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer